Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440115 · ClinicalTrials.gov registry record · Phase 3
Disease Management for Smoking Cessation
A Phase 3 study of Smoking Cessation, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 750
- Enrollment target
- 1
- Study location
NCT00440115: Completed Phase 3 study of Smoking Cessation, sponsored by University of Kansas Medical Center.
NCT00440115 is a Phase 3 study of Smoking Cessation that has completed, run by University of Kansas Medical Center. The registered enrollment target is 750 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00440115, a Phase 3 study of Smoking Cessation, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for smoking. The hypotheses are to compare abstinence from cigarettes, the number of quit attempts, and smokers motivation at 24 months between participants receiving high and low intensity disease management and those receiving usual care.
Primary Outcome
Self-reported 7-day point prevalence abstinence from cigarettes
Conditions Studied
Interventions
- DRUG Bupropion
- BEHAVIORAL High intensity disease management
- BEHAVIORAL Low intensity disease management
- BEHAVIORAL Comparison group
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
What the finished NCT00440115 record still lists
NCT00440115 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (59% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Bupropion is the first listed.
NCT00440115 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT00440115 about?
NCT00440115 is a clinical study titled "Disease Management for Smoking Cessation". The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for smoking. The hypotheses are to compare abstinence from cigarettes, the number of quit attempts, and smokers motivation at 24 months between participants receiving high and low...
What is the current status of trial NCT00440115?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 750 participants. The study started on 2009-06. Estimated completion is 2010-12.
What conditions does trial NCT00440115 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00440115?
The interventions under investigation include: Bupropion (DRUG), High intensity disease management (BEHAVIORAL), Low intensity disease management (BEHAVIORAL), Comparison group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00440115?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00440115 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00440115's enrollment target sits among peer trials
750 35th of 188 higher than 154 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tobacco Education and Lung Health Study (TEAL)
RECRUITING · Phase 3
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
-
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
RECRUITING · Phase 3
-
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
COMPLETED · Phase 3
-
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
COMPLETED · Phase 3
-
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia